Charles D Mackenzie

T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors

R. Eversole, J. Christie, Tiantian Zhang, 2017, Medical Oncology.

Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice

C. Nutting, R. Eversole, B. Tripp, 2015, Journal of Experimental & Clinical Cancer Research.

Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice

R. Eversole, B. Tripp, D. Jeng, 2015, Journal of experimental & clinical cancer research : CR.

Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells.

R. Eversole, Tiantian Zhang, K. Essani, 2018, Current cancer drug targets.